HIRO to Attend the SCDM Annual Conference 2026 in Raleigh, North Carolina

Find HiRO at SCDM 2026 at Booth #526 HiRO is excited to announce our attendance…

Article Date
August 4, 2026

This article is featured on another website.

Go to article

Related posts

Browse all articles
July 14, 2026

Chime Biologics Congratulates Polpharma Biologics on Global Licensing Agreement with Teva for Ocrelizumab Biosimilar Candidate

July 14, 2026

Chime Biologics Congratulates Polpharma Biologics on Global Licensing Agreement with Teva for Ocrelizumab Biosimilar Candidate

June 15, 2026

European Biopharmaceutical Review – GPCR-modulating Therapies for Solid Tumors: Unlocking a New Frontier in Immuno-oncology

June 15, 2026

European Biopharmaceutical Review – GPCR-modulating Therapies for Solid Tumors: Unlocking a New Frontier in Immuno-oncology